A Phase 2b 3-arm self-contained open-label controlled randomized trial is ongoing among healthy and Sm- and/or Sh-infected schoolchildren from the Senegal River Basin receiving a single dose of PZQ prior vaccination to further assess the safety and immunogenicity of Sm14/GLA-SE (NCT03799510) (113, 115)
The compound received marketing approval in China in June 2025 under the brand name Xinermei, making it the first domestically approved dual GLP-1/glucagon agonist anywhere in the world
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a recombinant analog of human IGF-1, engineered to overcome the pharmacokinetic limitations of the native hormone
Assessing the effect of Alpinia galanga extract on the treatment of SSRI-induced erectile dysfunction: A randomized triple-blind clinical trial
Build Your Quote: Zero Interest Payments: Buy Now, Pay Later with premium financing packages only available on Sauna Marketplace
Uwzgldniam Twoje ulubione smaki, tryb pracy, moliwoci czasowe